Sam Altman-backed AI biotech announces $1 billion for its lofty goal: adding 10 years to human life span
Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Retro Biosciences, backed by Sam Altman, is raising $1 billion to extend human lifespan
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
Sam Altman denies AGI release as reports swirl about US government meetings
With speculation online about OpenAI having reached the AGI stage of ChatGPT development, Sam Altman says that's not what's ...
India Today on MSN39m
Sam Altman compares Operator launch to ChatGPT: Here is how they are different
OpenAI has recently released its first AI agent, Operator. But how is it different from the ChatGPT platform? Let's find out.
Sam Altman’s World now wants to link AI agents to your digital identity
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Australia’s head not in the AI game
The prime minister’s bumbling answer to a press club question on Australia’s engagement in the AI arms race shows how ...
Trump 2nd term live updates: President takes pride in getting rid of 'woke crap'
More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...